Tag Archives: IGI

Business, Finance, Occupation & Industry

Western Asset Investment Grade Defined Opportunity Trust Inc. Announces Results of Annual Meeting of

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Western Asset Investment Grade Defined Opportunity Trust Inc. Announces Results of Annual Meeting of Shareholders

NEW YORK–(BUSINESS WIRE)– Western Asset Investment Grade Defined Opportunity Trust Inc. (the “Fund”), which is traded on the New York Stock Exchange under the symbol “IGI,” announced today the results of the votes cast at the Fund’s annual meeting of shareholders held March 25, 2013.

Carol L. Colman, Daniel P. Cronin, and Paolo M. Cucchi were elected as Class I Directors of the Fund by owners of its common stock to hold office until the annual meeting of shareholders in the year 2016 or thereafter when respective successors are duly elected and qualified or until they resign or are otherwise removed.

Eileen A. Kamerick was elected as a Class III Director of the Fund by owners of its common stock to hold office until the annual meeting of shareholders in the year 2015 or thereafter when respective successors are duly elected and qualified or until she resigns or is otherwise removed.

Western Asset Investment Grade Defined Opportunity Trust Inc. is a non-diversified, limited-term, closed-end management investment company that is managed by Legg Mason Partners Fund Advisor, LLC, a wholly-owned subsidiary of Legg Mason, Inc. It is sub-advised by Western Asset Management Company (“WAMCo”) and certain of WAMCo’s foreign-based affiliates; WAMCo and its affiliates are also affiliates of the investment manager.

Contact the Fund at 1-888-777-0102 for more information, or visit the Fund’s web site at www.lmcef.com.

Data and commentary provided in this press release are for informational purposes only. Legg Mason, Inc. and its affiliates do not engage in selling shares of the Fund.

Media
Western Asset Investment Grade Defined Opportunity Trust Inc.
Maria Rosati, (212)-805-6036
mrosati@leggmason.com

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:

The article Western Asset Investment Grade Defined Opportunity Trust Inc. Announces Results of Annual Meeting of Shareholders originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved.

From: http://www.dailyfinance.com/2013/04/11/western-asset-investment-grade-defined-opportunity/

Business, Finance, Occupation & Industry

IGI Laboratories to Hold Conference Call for 1st Quarter 2013 Results

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

IGI Laboratories to Hold Conference Call for 1st Quarter 2013 Results

BUENA, N.J.–(BUSINESS WIRE)– IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Thursday, April 25, 2013 to discuss 1st quarter 2013 results.

The Company invites you to listen to the call by dialing 1-866-515-2913. International participants should call 1-617-399-5127. The passcode for the conference call is 36836952.

This call is being webcast by Thomson and can be accessed at IGI‘s website at www.igilabs.com.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson’s individual investor portal, powered by StreetEvents (www.streetevents.com), a password-protected event management site.

About IGI Laboratories, Inc.

IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.

IGI Laboratories, Inc.
Jenniffer Collins, 856-697-1441
www.igilabs.com

KEYWORDS:   United States  North America  New Jersey

INDUSTRY KEYWORDS:

The article IGI Laboratories to Hold Conference Call for 1st Quarter 2013 Results originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);

From: http://www.dailyfinance.com/2013/04/11/igi-laboratories-to-hold-conference-call-for-1st-q/

Business, Finance, Occupation & Industry

IGI Laboratories Announces 4th Quarter 2012 and Year End 2012 Results

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

IGI Laboratories Announces 4 th Quarter 2012 and Year End 2012 Results

BUENA, N.J.–(BUSINESS WIRE)– IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the fourth quarter and year ended December 31, 2012.

Fourth Quarter 2012 Highlights vs. 2011

  • Total Revenues of $2.3 million, increase of 10% over same quarter in 2011
  • Invested in the infrastructure of our commercialization strategy and successfully launched the first ever IGI label generic topical pharmaceutical products
  • Raised approximately $2.0 million in cash through the sale of treasury stock to fund the purchase of the topical pharmaceutical product econazole nitrate cream 1%
  • Net loss was $1.2 million and $0.5 million for the fourth quarter of 2012 and 2011
  • Net loss included research and development costs of $1.1 and $0.6 million in 2012 and 2011
  • Increase in research and development costs in the fourth quarter of 2012 over the same quarter last year due to additional costs related to approximately $0.3 million of Generic Drug User Fee Amendments of 2012 (GDUFA) fees required by the US FDA and $0.3 million of costs related to clinical studies

Year to Date 2012 Highlights vs. 2011

  • Total Revenues of $8.6 million in 2012, an increase of 10% over 2011
  • Net loss was $3.9 million in 2012 as compared to a net loss of $3.0 million in 2011
  • Net loss included research and development costs of $2.8 million and $2.2 million in 2012 and 2011
  • IGI has filed nine Abbreviated New Drug Applications (ANDAs) to date

IGI‘s President and Chief Executive Officer, Jason Grenfell-Gardner, stated, “I am extremely pleased with the progress IGI made in 2012. We launched the first ever IGI labeled topical pharmaceutical product; we filed five ANDAs with the US FDA, three for our own pipeline; we hired a proven …read more
Source: FULL ARTICLE at DailyFinance